COMBINATION THERAPHY OF AN ANTI CD20 ANTIBODY WITH A BTK INHIBITOR

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG;ONO PHARMACEUTICAL CO., LTD.

发明人:

KLEIN, CHRISTIAN,TOSHIO, YOSHIZAWA,TOMOKO, YASUHIRO

申请号：

PH12016500839

公开号：

PH12016500839A1

申请日:

2016.05.05

申请国别(地区):

PH

年份:

2016

代理人:

摘要：

The present invention is directed to the combination therapy of an anti-CD20 antibody with a BTK inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Lyl antibody and a BTK inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/